Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-17 Purchase | 2023-11-21 12:19 pm | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 25,000 | $1.09 | $27,250 | 79,000 (Direct) | View |
| 2023-11-16 Purchase | 2023-11-20 10:07 am | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 50,000 | $0.9399 | $46,995 | 54,000 (Direct) | View |
| 2023-11-16 Purchase | 2023-11-17 12:37 pm | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 150,000 | $0.9198 | $137,970 | 186,496 (Direct) | View |
| 2023-11-16 Purchase | 2023-11-17 12:36 pm | HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer | 85,000 | $0.8894 | $75,599 | 85,000 (Direct) | View |
| 2023-07-21 Purchase | 2023-07-25 4:22 pm | HERON THERAPEUTICS INC. | HRTX | Morgan Adam Director | 2,486,744 | $1.37 | $3,406,839 | 8,187,514 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-03 Exercise | 2024-04-05 3:57 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 62,500 | $0 | 436,496 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-19 9:05 pm | N/A 2034-01-19 | HERON THERAPEUTICS INC. | HRTX | Christian Waage Director | 97,633 | $0 | 149,865 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-19 9:04 pm | N/A 2034-01-19 | HERON THERAPEUTICS INC. | HRTX | Rodriguez Susan Director | 97,633 | $0 | 152,915 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-19 9:04 pm | N/A 2034-01-19 | HERON THERAPEUTICS INC. | HRTX | Morgan Adam Director | 97,633 | $0 | 7,122,256 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-19 9:03 pm | N/A 2034-01-19 | HERON THERAPEUTICS INC. | HRTX | Johnson Craig A Director | 97,633 | $0 | 149,505 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-19 9:02 pm | N/A 2034-01-19 | HERON THERAPEUTICS INC. | HRTX | Dissanaike Sharmila Director | 97,633 | $0 | 152,915 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-19 9:01 pm | N/A 2034-01-19 | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 47,924 | $0 | 47,924 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-19 9:01 pm | N/A 2034-01-19 | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 433,924 | $0 | 433,924 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-19 9:00 pm | N/A 2034-01-19 | HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer | 433,924 | $0 | 433,924 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-19 8:58 pm | N/A 2034-01-19 | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 1,545,252 | $0 | 1,545,252 (Direct) | View |
| 2024-01-13 Exercise | 2024-01-16 5:19 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 1,841 | $0 | 64,238 (Direct) | View |
| 2024-01-13 Tax Withholding | 2024-01-16 5:19 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 756 | $2.15 | 64,238 (Direct) | View |
| 2023-07-25 Exercise | 2023-10-17 7:57 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 45,115 | $0 | 64,994 (Direct) | View |
| 2023-10-13 Tax Withholding | 2023-10-17 7:57 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 860 | $0.72 | 64,994 (Direct) | View |
| 2023-07-25 Tax Withholding | 2023-10-17 7:57 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 14,743 | $1.51 | 64,994 (Direct) | View |
| 2023-08-22 Tax Withholding | 2023-08-24 4:09 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 692 | $1.65 | 36,496 (Direct) | View |
Ownership | 2023-07-25 4:15 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Rubric Capital Management LP Rosen David Efraim 10% Owner | 0 | $0 | 26,713,503 (Indirect) | View |
| 2023-07-17 Option Award | 2023-07-19 6:21 pm | N/A 2033-07-17 | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-07-13 Exercise | 2023-07-17 5:51 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer | 5,814 | $0 | 63,376 (Direct) | View |
| 2023-07-13 Tax Withholding | 2023-07-17 5:51 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer | 2,012 | $1.31 | 63,376 (Direct) | View |
| 2023-07-13 Exercise | 2023-07-17 5:51 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 2,485 | $0 | 37,966 (Direct) | View |
| 2023-07-13 Tax Withholding | 2023-07-17 5:51 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 860 | $1.31 | 37,966 (Direct) | View |
Ownership | 2023-06-23 4:28 pm | N/A 2033-06-16 | HERON THERAPEUTICS INC. | HRTX | Duarte Ira EVP, Chief Financial Officer | 0 | $0 | 1,350,000 (Direct) | View |
Ownership | 2023-06-12 4:41 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Forbes William P EVP, Chief Development Officer | 0 | $0 | 1,254,000 (Direct) | View |
| 2023-05-22 Tax Withholding | 2023-05-24 5:04 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 691 | $1.45 | 37,188 (Direct) | View |
| 2023-04-13 Exercise | 2023-04-17 5:28 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer | 5,814 | $0 | 65,388 (Direct) | View |
| 2023-04-13 Tax Withholding | 2023-04-17 5:28 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer | 2,012 | $2.88 | 65,388 (Direct) | View |
| 2023-04-13 Exercise | 2023-04-17 5:27 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO | 5,814 | $0 | 82,084 (Direct) | View |
| 2023-04-13 Tax Withholding | 2023-04-17 5:27 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO | 2,012 | $2.88 | 82,084 (Direct) | View |
| 2023-04-13 Exercise | 2023-04-17 5:27 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 2,484 | $0 | 38,826 (Direct) | View |
| 2023-04-13 Tax Withholding | 2023-04-17 5:27 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 860 | $2.88 | 38,826 (Direct) | View |
| 2023-04-13 Exercise | 2023-04-17 5:26 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 5,814 | $0 | 63,766 (Direct) | View |
| 2023-04-13 Tax Withholding | 2023-04-17 5:26 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 1,417 | $2.88 | 63,766 (Direct) | View |
| 2023-04-03 Option Award | 2023-04-05 5:10 pm | N/A 2033-04-03 | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Chief Executive Officer | 7,500,000 | $0 | 7,500,000 (Direct) | View |
Ownership | 2023-03-02 4:13 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | KOTLER KEVIN Director | 0 | $0 | 805,151 (Direct) | View |
Ownership | 2023-03-02 4:11 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Collard Craig A Director | 0 | $0 | 265,151 (Direct) | View |
| 2023-02-22 Option Award | 2023-02-24 7:20 pm | N/A 2033-02-22 | HERON THERAPEUTICS INC. | HRTX | Morgan Adam See Notes 2 & 3 | 265,151 | $0 | 4,765,151 (Direct) | View |
Ownership | 2023-02-08 6:26 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Velan Capital Investment Management LP Velan Capital Master Fund LP Velan Capital Holdings LLC Velan Capital Management LLC VENKATARAMAN BALAJI Morgan Adam See Footnote 2 | 0 | $0 | 4,500,000 (Indirect) | View |
Ownership | 2023-02-08 6:23 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Rubric Capital Management LP Rosen David Efraim See Footnote 1 | 0 | $0 | 11,750,000 (Indirect) | View |
| 2023-01-18 Option Award | 2023-01-20 5:10 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Szekeres David Leslie EVP, Chief Operating Officer | 49,788 | $0 | 49,788 (Direct) | View |
| 2023-01-18 Option Award | 2023-01-20 5:10 pm | N/A 2033-01-18 | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 850,000 | $0 | 850,000 (Direct) | View |
| 2023-01-18 Option Award | 2023-01-20 5:09 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | POYHONEN JOHN President & CCO | 66,385 | $0 | 66,385 (Direct) | View |
| 2023-01-18 Option Award | 2023-01-20 5:09 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Peraza Lisa VP, Chief Accounting Officer | 42,631 | $0 | 42,631 (Direct) | View |
| 2023-01-18 Option Award | 2023-01-20 5:08 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development | 149,365 | $0 | 149,365 (Direct) | View |